Telix Pharmaceuticals | TLX - Current Assets

Stock Price
10.12
Daily Change
-0.09 -0.88%
Monthly
-10.04%
Yearly
-65.28%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD918.56M in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Cochlear AUD 1.42B 6.2M Jun/2025
CSL USD 11.85B 542M Jun/2025
Integral Diagnostics AUD 74.82M 9.15M Jun/2024
Mayne Pharma AUD 460.59M 14.71M Jun/2024
Medical Developments International AUD 35.54M 2.13M Jun/2025
Mesoblast USD 204.35M 134.67M Jun/2025
Neuren Pharmaceuticals AUD 320.25M 79.08M Jun/2025
Pacific Edge NZD 29.58M 1.24M Dec/2025
Paradigm Biopharmaceuticals AUD 24.13M 8.16M Jun/2025
Polynovo AUD 79.3M 9.02M Jun/2024
PYC Therapeutics AUD 177.53M 115.4M Jun/2025
Ramsay Health Care AUD 4.04B 632.8M Jun/2025
ResMed USD 3.82B 193.06M Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024